Oscar Health, Inc. (OSCR) stock plummeted 13.29% in the pre-market trading session on Wednesday, following the company's disappointing fourth-quarter 2024 earnings report and lackluster full-year 2025 revenue guidance.
The health insurer reported a wider-than-expected loss for the fourth quarter, with an earnings per share loss of $0.62, missing the consensus estimate of a $0.58 loss. Revenue for the quarter also fell short of expectations, coming in at $2.39 billion, compared to the estimated $2.47 billion. Higher medical costs were cited as a key factor behind the earnings miss.
Adding to investor concerns, Oscar Health provided underwhelming full-year 2025 revenue guidance of $11.2-11.3 billion, falling short of the consensus estimate of $11.69 billion. This raised questions about the company's growth prospects, overshadowing its forecast of a return to profitability in 2025, with expected earnings from operations between $225-275 million.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.